US

Shawn C Miller

This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn C Miller. Retrieved from https://idiyas.com/inventor/shawn-c-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Shawn C Miller: Innovator in Antiviral and Antineoplastic Research

Introduction

Shawn C Miller is a notable inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and antineoplastic agents. His innovative work focuses on novel compounds that have the potential to combat various diseases.

Latest Patents

Shawn C Miller holds a patent for "Carbo-Acyclic Nucleoside Derivatives As Antiviral And Antineoplastic Agents." This invention is directed towards a class of novel carbo-acyclic derivatives characterized by specific chemical formulas. These compounds are designed for use as antiviral and anti-neoplastic agents, showcasing their potential in medical applications.

Career Highlights

Miller is associated with Merrell Pharmaceuticals, Inc., where he has been involved in groundbreaking research. His work emphasizes the importance of developing new therapeutic agents that can address pressing health challenges. Despite having no patents listed under his name, his contributions to the field are noteworthy.

Collaborations

Throughout his career, Shawn C Miller has collaborated with esteemed colleagues, including Jeffrey S Sabol and Sai Prasad Sunkara. These partnerships have likely enhanced the scope and impact of his research efforts.

Conclusion

Shawn C Miller is a dedicated inventor whose work in antiviral and antineoplastic research holds promise for future medical advancements. His innovative approach to drug development continues to inspire progress in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…